Michael Tetzlaff, MD, PhD

Dr Michael Tetzlaff recently moved to UCSF from the Department of Pathology and Translational and Molecular Pathology at the MD Anderson Cancer Centre at The University of Texas. Prof Tetzlaff' s main area of expertise is in primary mucosal melanoma and merkel cell carcinoma, and assisting in the assessment of pathological samples from patients undergoing neoadjuvant, targeted therapy. He is the author of over 100 peer-reviewed journal articles

Dr Michael Tetzlaff recently moved to UCSF from the Department of Pathology and Translational and Molecular Pathology at the MD Anderson Cancer Centre at The University of Texas. Prof Tetzlaff' s main area of expertise is in primary mucosal melanoma and merkel cell carcinoma, and assisting in the assessment of pathological samples from patients undergoing neoadjuvant, targeted therapy. He is the author of over 100 peer-reviewed journal articles See less